Oral cladribine discontinued for MS


Oral cladribine will not be marketed for multiple sclerosis and the drug will be pulled in countries where it has already received approval, according to an announcement from manufacturer Merck KGaA.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page